Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice

被引:3
作者
Abdul-Hai, Ali
Ben-Yehuda, Arie
Galsky, Haya
Slavin, Shimon [1 ]
Or, Reuven
机构
[1] Hadassah Univ Hosp, Dept Bone Marrow Transplantat & Canc Immunotherap, Cell Therapy & Transplantat Res Ctr, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Hadassah Univ Hosp, Dept Cell Biol, IL-91120 Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Internal Med, Sch Med, IL-91120 Jerusalem, Israel
关键词
interleukin; 2; marrow transplantation; immune function; thymus; spleen; mice;
D O I
10.1007/s00262-006-0125-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Success of allogeneic and autologous bone marrow transplantation (BMT) is hampered by susceptibility to infection during the first two post-treatment years. Further, in treating malignant diseases, impaired anti-host reactivity for donor cells may contribute to a high rate of relapse. Both complications are a consequence of immune deficiency involving B and T lymphocytes. The present study evaluates several key parameters of the immunologic reconstitution mechanism in mice subjected to myeloablative total body irradiation following semi-allogeneic ( parental) BMT. This resulted in a gradual reduction of splenic CD3, CD4 and CD8 cells until day 45 post-BMT. Concomitantly, there was an increase in monocytes and CD4(+)/ CD8(+) ( double positive) cells, accompanied by a persistent elevation in the percentage of B lymphocytes. The total thymic and splenic T cell populations were reduced until day +30. The cellular reduction correlated with the poor proliferative response of the thymic and splenic cells. A decrease occurred in IL-2 mRNA expression in thymic cells during days 15-20 post-transplant, corresponding with the low level of IL-2 secretion in the spleen and thymus of the transplanted mice. In conclusion, following semi-allogeneic BMT, there was an overall immune down-regulation in the cells, gene and protein levels. Reduced immunological responsiveness following BMT reinforces the need for improving the immune dysfunction by immunotherapy post-BMT.
引用
收藏
页码:1330 / 1336
页数:7
相关论文
共 29 条
[1]   INVOLVEMENT OF INTERLEUKIN-2 IN IMMUNOLOGICAL RECONSTITUTION FOLLOWING BONE-MARROW TRANSPLANTATION IN MICE [J].
ABDULHAI, A ;
LORBERBOUMGLISKI, H ;
MECHUSHTAN, A ;
WEISS, L ;
SLAVIN, S ;
OR, R .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (01) :95-101
[2]   Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease [J].
Alpdogan, O ;
Schmaltz, C ;
Muriglan, SJ ;
Kappel, BJ ;
Perales, MA ;
Rotolo, JA ;
Halm, JA ;
Rich, BE ;
van den Brink, MRM .
BLOOD, 2001, 98 (07) :2256-2265
[3]   Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation [J].
Alyea, EP ;
Weller, E ;
Fisher, DC ;
Freedman, AS ;
Gribben, YG ;
Lee, S ;
Schlossman, RL ;
Stone, RM ;
Friedberg, Y ;
DeAngelo, D ;
Liney, D ;
Windawi, S ;
Ng, A ;
Mauch, P ;
Antin, JH ;
Soiffer, RJ .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (11) :601-607
[4]   IL-7 effect on immunological reconstitution after HSCT depends on MHC incompatibility [J].
André-Schmutz, I ;
Bonhomme, DS ;
Yates, F ;
Malassis, M ;
Selz, F ;
Fischer, A ;
Cavazzana-Calvo, M .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (06) :844-851
[5]  
ATKINSON K, 1990, BONE MARROW TRANSPL, V5, P209
[6]  
Bolotin E, 1996, BLOOD, V88, P1887
[7]  
Bornhäuser M, 2000, HAEMATOLOGICA, V85, P839
[8]   SECRETION OF IL-2, IL-3, IL-4, IL-6 AND GM-CSF BY CD4+ AND CD8+ TCR-ALPHA-BETA+ T-CELL CLONES DERIVED EARLY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
BRUSERUD, O ;
EHNINGER, G ;
HAMANN, W ;
PAWELEC, G .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1993, 38 (01) :65-74
[9]   Interleukin 2 plays a central role in Th2 differentiation [J].
Cote-Sierra, J ;
Foucras, G ;
Guo, LY ;
Chiodetti, L ;
Young, HA ;
Hu-Li, J ;
Zhu, JF ;
Paul, WE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (11) :3880-3885
[10]   Interleukin-2 is essential for CD4+CD25+ regulatory T cell function [J].
de la Rosa, M ;
Rutz, S ;
Dorninger, H ;
Scheffold, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (09) :2480-2488